Optic nerve head hemoglobin measurements help in early diagnosis of primary open angle glaucoma: Study
In a new study published in Glaucoma, it was seen that using measurements of optic nerve head (ONH) hemoglobin concentrations, the Laguna ONhE program may offer a reliable and affordable method of identifying early primary open angle glaucoma (POAG).
The Laguna ONhE, a program that analyses fundus photos to determine the hemoglobin (Hb) content of the optic nerve head, showed high accuracy in differentiating between healthy and eyes with moderate glaucoma. In order to differentiate between healthy eyes and eyes with moderate glaucoma, Livia Studart de Meneses and colleagues conducted this investigation with the goal of measuring the Hb content of the optic nerve.
For this study, both healthy volunteers (n=64) and patients with mild primary open angle glaucoma (MD > 6 dB) had their eyes chosen. All eyes' retinal nerve fiber layer thicknesses were measured using optical coherence tomography. Additionally, optic disc pictures were acquired, and the images were examined using the Laguna ONhE program, which calculates the quantity of Hb in 24 ONH sectors. The Glaucoma Discriminant Function (GDF), an index that quantifies the likelihood that the ONH is consistent with glaucoma, is also computed by the program. Each Laguna ONhE parameter's areas under the receiver operating characteristic curve and sensitivities at preset specificities of 90% and 95% were computed.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.